Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer

To investigate the exposure–safety relationships of afatinib in Japanese population, we performed population pharmacokinetics (PK) analysis of afatinib in Japanese advanced non-small cell lung cancer patients harboring epidermal growth factor receptor mutation. Plasma samples were collected at 0.5–1...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakao, Keiko, Kobuchi, Shinji, Marutani, Shuhei, Iwazaki, Ayano, Tamiya, Akihiro, Isa, Shunichi, Okishio, Kyoichi, Kanazu, Masaki, Tamiya, Motohiro, Hirashima, Tomonori, Imai, Kimie, Sakaeda, Toshiyuki, Atagi, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890782/
https://www.ncbi.nlm.nih.gov/pubmed/31796841
http://dx.doi.org/10.1038/s41598-019-54804-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890782/
https://www.ncbi.nlm.nih.gov/pubmed/31796841
http://dx.doi.org/10.1038/s41598-019-54804-9

Ejemplares similares